von Willebrand factor: the old, the new and the unknown
暂无分享,去创建一个
C. Casari | O. Christophe | P. Lenting | C. Denis | P J Lenting | C V Denis | P. Lenting | C Casari | O D Christophe
[1] P. Mannucci,et al. Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN) , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.
[2] C. Casari,et al. Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5 , 2012, Haematologica.
[3] E. Herczenik,et al. Shear stress is required for the endocytic uptake of the factor VIII‐von Willebrand factor complex by macrophages , 2012, Journal of thrombosis and haemostasis : JTH.
[4] R. Schutgens,et al. Von Willebrand factor deficiency and atherosclerosis. , 2012, Blood reviews.
[5] D. Wagner,et al. Neutrophil extracellular trap (NET) impact on deep vein thrombosis. , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[6] D. Motto,et al. ADAMTS13 reduces VWF‐mediated acute inflammation following focal cerebral ischemia in mice , 2012, Journal of thrombosis and haemostasis : JTH.
[7] T. Walz,et al. Sequence and structure relationships within von Willebrand factor. , 2012, Blood.
[8] H. Okano,et al. Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor. , 2012, Journal of the National Cancer Institute.
[9] W. Hauswirth,et al. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] S. Neelamegham,et al. von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion. , 2012, Blood.
[11] P. James,et al. von Willebrand disease: Clinical and laboratory lessons learned from the large von Willebrand disease studies , 2012, American journal of hematology.
[12] D. Lillicrap,et al. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W , 2012, Journal of thrombosis and haemostasis : JTH.
[13] R. Bierings,et al. Proteomic screen identifies IGFBP7 as a novel component of endothelial cell-specific Weibel-Palade bodies. , 2012, Journal of proteome research.
[14] P. Mannucci,et al. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients , 2012, Journal of thrombosis and haemostasis : JTH.
[15] Riyao Yang,et al. Galectins in acute and chronic inflammation , 2012, Annals of the New York Academy of Sciences.
[16] P. D. de Groot,et al. Identification of Galectin-1 and Galectin-3 as Novel Partners for Von Willebrand Factor , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[17] A. Chauhan,et al. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. , 2012, Blood.
[18] C. Casari,et al. Macrophage LRP1 contributes to the clearance of von Willebrand factor. , 2012, Blood.
[19] Michael M. Wang,et al. von Willebrand Factor Permeates Small Vessels in CADASIL and Inhibits Smooth Muscle Gene Expression , 2012, Translational Stroke Research.
[20] E. Boerwinkle,et al. Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study. , 2012, Blood.
[21] D. Wagner,et al. An Emerging Target in Stroke Therapy , 2012 .
[22] D. Wagner,et al. Neutrophil extracellular traps promote deep vein thrombosis in mice , 2012, Journal of thrombosis and haemostasis : JTH.
[23] L. Thim,et al. High Affinity Binding of FVIII to VWF Is Not Required for the Haemostatic Effect of FVIII In Vivo , 2011 .
[24] T. Walz,et al. A pH‐regulated dimeric bouquet in the structure of von Willebrand factor , 2011, The EMBO journal.
[25] D. Lane,et al. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. , 2011, Blood.
[26] P. D. de Groot,et al. Cleavage of von Willebrand Factor by Granzyme M Destroys Its Factor VIII Binding Capacity , 2011, PloS one.
[27] R. Schneppenheim,et al. von Willebrand factor: the complex molecular genetics of a multidomain and multifunctional protein , 2011, Journal of thrombosis and haemostasis : JTH.
[28] T. Springer,et al. Biology and physics of von Willebrand factor concatamers , 2011, Journal of thrombosis and haemostasis : JTH.
[29] D. Strachan,et al. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. , 2011, Blood.
[30] F. Leebeek,et al. Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review , 2011, Journal of thrombosis and haemostasis : JTH.
[31] D. Lillicrap,et al. Pathologic mechanisms of type 1 VWD mutations R1205H and Y1584C through in vitro and in vivo mouse models. , 2011, Blood.
[32] B. Lämmle,et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. , 2011, Blood.
[33] A. Hughes,et al. Endothelial von Willebrand factor regulates angiogenesis. , 2011, Blood.
[34] J. Moake,et al. Disulfide bond reduction of von Willebrand factor by ADAMTS‐13 , 2010, Journal of thrombosis and haemostasis : JTH.
[35] A. Zarbock,et al. von Willebrand factor promotes leukocyte extravasation. , 2010, Blood.
[36] Junmei Chen,et al. Shear stress-induced unfolding of VWF accelerates oxidation of key methionine residues in the A1A2A3 region. , 2010, Blood.
[37] M. Slaughter. Hematologic Effects of Continuous Flow Left Ventricular Assist Devices , 2010, Journal of cardiovascular translational research.
[38] J. Hartwig,et al. Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.
[39] D. Lillicrap,et al. Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions. , 2010, Blood.
[40] P. Legendre,et al. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B. , 2010, Blood.
[41] F. Rosendaal,et al. Risk factors for venous thrombosis – current understanding from an epidemiological point of view , 2010, British journal of haematology.
[42] T. Miyata,et al. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion. , 2010, Blood.
[43] S. Rutella,et al. Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stress. , 2010, Free radical biology & medicine.
[44] C. Ruan,et al. The glycoprotein Ibα–von Willebrand factor interaction induces platelet apoptosis , 2010, Journal of thrombosis and haemostasis : JTH.
[45] Junmei Chen,et al. Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. , 2010, Blood.
[46] B. Sorg,et al. Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasia. , 2009, The Journal of clinical investigation.
[47] Y. Asada,et al. Critical role of von Willebrand factor and platelet interaction in venous thromboembolism. , 2009, Histology and histopathology.
[48] A. Chauhan,et al. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke. , 2009, Blood.
[49] R. Montgomery,et al. Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site. , 2009, Blood.
[50] A. Tosetto,et al. How I treat von Willebrand disease. , 2009, Blood.
[51] R. Westrick,et al. Modifier genes for disorders of thrombosis and hemostasis , 2009, Journal of thrombosis and haemostasis : JTH.
[52] Cheng-Zhong Zhang,et al. Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor , 2009, Science.
[53] H. Deckmyn,et al. von Willebrand factor to the rescue. , 2009, Blood.
[54] R. Kiss,et al. Galectins and Gliomas , 2009, Brain pathology.
[55] G. Stoll,et al. Deficiency of von Willebrand factor protects mice from ischemic stroke. , 2009, Blood.
[56] J. Zachary,et al. von-Willebrand factor influences blood brain barrier permeability and brain inflammation in experimental allergic encephalomyelitis. , 2008, The American journal of pathology.
[57] A. Chauhan,et al. Abbreviations used: AD- , 2022 .
[58] P. Bird,et al. Antihemostatic Activity of Human Granzyme B Mediated by Cleavage of von Willebrand Factor* , 2008, Journal of Biological Chemistry.
[59] J. Moake,et al. Covalent regulation of ULVWF string formation and elongation on endothelial cells under flow conditions , 2008, Journal of thrombosis and haemostasis : JTH.
[60] P. Lenting,et al. Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13 , 2008, Proceedings of the National Academy of Sciences.
[61] P. James,et al. Von Willebrand disease. , 2008, Pediatric clinics of North America.
[62] R. Bierings,et al. Efficiency of von Willebrand factor‐mediated targeting of interleukin‐8 into Weibel–Palade bodies , 2007, Journal of thrombosis and haemostasis : JTH.
[63] P. D. de Groot,et al. beta2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. , 2007, Blood.
[64] O. Christophe,et al. Characterization of the interaction between von Willebrand factor and osteoprotegerin , 2007, Journal of thrombosis and haemostasis : JTH.
[65] A Alexander-Katz,et al. Shear-induced unfolding triggers adhesion of von Willebrand factor fibers , 2007, Proceedings of the National Academy of Sciences.
[66] P. D. de Groot,et al. Correction of the bleeding time in von Willebrand factor (VWF)-deficient mice using murine VWF. , 2007, Blood.
[67] P. Hogg,et al. Hypothesis for control of von Willebrand factor multimer size by intra‐molecular thiol‐disulphide exchange , 2007, Journal of thrombosis and haemostasis : JTH.
[68] C. Gahmberg,et al. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von Willebrand factor. , 2006, Blood.
[69] A. Chauhan,et al. HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins , 2007 .
[70] P. Mannucci,et al. Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor , 2006, Journal of thrombosis and haemostasis : JTH.
[71] T. Pullen,et al. P-selectin binds to the D'-D3 domains of von Willebrand factor in Weibel-Palade bodies. , 2006, Blood.
[72] D Meyer,et al. Increased metastatic potential of tumor cells in von Willebrand factor‐deficient mice , 2006, Journal of thrombosis and haemostasis : JTH.
[73] A. Federici,et al. Activation-independent platelet adhesion and aggregation under elevated shear stress. , 2005, Blood.
[74] Heather A. Mitchell,et al. Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin. , 2005, Blood.
[75] D. Ogden,et al. Differential Kinetics of Cell Surface Loss of von Willebrand Factor and Its Propolypeptide after Secretion from Weibel-Palade Bodies in Living Human Endothelial Cells* , 2005, Journal of Biological Chemistry.
[76] J. Moake,et al. Platelets adhered to endothelial cell‐bound ultra‐large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress , 2005, Journal of thrombosis and haemostasis : JTH.
[77] C. Balduini,et al. Signalling through the platelet glycoprotein Ib-V-IX complex. , 2004, Cellular signalling.
[78] P. Mannucci,et al. Plasma levels of von Willebrand factor regulate ADAMTS‐13, its major cleaving protease , 2004, British journal of haematology.
[79] J. Pimanda,et al. Role of Thrombospondin-1 in Control of von Willebrand Factor Multimer Size in Mice* , 2004, Journal of Biological Chemistry.
[80] P. Legendre,et al. von Willebrand factor C1C2 domain is involved in platelet adhesion to polymerized fibrin at high shear rate. , 2004, Blood.
[81] S. Susen,et al. Acquired von Willebrand syndrome in aortic stenosis. , 2003, The New England journal of medicine.
[82] H. Dardik,et al. Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies. , 2003, Journal of vascular surgery.
[83] A. Folsom,et al. Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE). , 2002, The American journal of medicine.
[84] D. Wagner,et al. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. , 2001, Blood.
[85] C. Denis,et al. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[86] R. Montgomery,et al. von Willebrand factor storage and multimerization: 2 independent intracellular processes. , 2000, Blood.
[87] P. Lenting,et al. The life cycle of coagulation factor VIII in view of its structure and function. , 1998, Blood.
[88] G. E. Gilbert,et al. Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers. , 1998, Blood.
[89] C. Vrints,et al. Fibrin(ogen) and von Willebrand factor deposition are associated with intimal thickening after balloon angioplasty of the rabbit carotid artery. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[90] R. Marchant,et al. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. , 1996, Blood.
[91] J. Vandenbroucke,et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.
[92] É. Fressinaud,et al. International Survey of Patients with von Willebrand Disease and Angiodysplasia , 1993, Thrombosis and Haemostasis.
[93] D. Wagner. The Weibel-Palade Body: the Storage Granule for von Willebrand Factor and P-selectin , 1993, Thrombosis and Haemostasis.
[94] D. Baruch,et al. Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.
[95] D. A. Beacham,et al. Selective inactivation of the Arg-Gly-Asp-Ser (RGDS) binding site in von Willebrand factor by site-directed mutagenesis. , 1992, The Journal of biological chemistry.
[96] B. Duim,et al. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor. , 1991, The Biochemical journal.
[97] D. Tate,et al. von Willebrand factor and occlusive arterial thrombosis. A study in normal and von Willebrand's disease pigs with diet-induced hypercholesterolemia and atherosclerosis. , 1990, Arteriosclerosis.
[98] J. Voorberg,et al. 5 Molecular cloning, expression and assembly of multimeric von Willebrand factor* , 1989 .
[99] S. Orkin,et al. The propeptide of von Willebrand Factor independently mediates the assembly of von Willebrand multimers , 1988, Cell.
[100] J. McPherson,et al. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. , 1987, The Journal of biological chemistry.
[101] K. Titani,et al. von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. , 1986, The Journal of biological chemistry.
[102] C. Soria,et al. [Coagulation factors in inflammation]. , 1971, Arzneimittel-Forschung.
[103] S. Jasko,et al. Therapy , 1881, The American journal of dental science.
[104] J. Stockman. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis , 2013 .
[105] C. Casari,et al. Macrophage LRP 1 contributes to the clearance of von Willebrand factor , 2012 .
[106] P. Legendre,et al. Mutation and ADAMTS 13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2 B * , 2010 .
[107] J. Sadler,et al. Low von Willebrand factor: sometimes a risk factor and sometimes a disease. , 2009, Hematology. American Society of Hematology. Education Program.
[108] C. Denis,et al. Role of von Willebrand factor in tumor metastasis. , 2007, Thrombosis research.
[109] Xiaoqi Q Ding,et al. Intracranial hemorrhage in a term newborn with severe von Willebrand disease type 3 associated with sinus venous thrombosis. , 2006, Haematologica.
[110] B. Lämmle,et al. Recovery and Half-Life of von Willebrand Factor-Cleaving Protease after Plasma Therapy in Patients with Thrombotic Thrombocytopenic Purpura , 1999, Thrombosis and Haemostasis.
[111] J. Vermylen,et al. Antagonism of vWF Inhibits both Injury Induced Arterial and Venous Thrombosis in the Hamster , 1998, Thrombosis and Haemostasis.
[112] D. Ginsburg,et al. Von Willebrand disease. , 2008, Pediatric clinics of North America.
[113] J. Voorberg,et al. Molecular cloning, expression and assembly of multimeric von Willebrand factor. , 1989, Bailliere's clinical haematology.